Zoetis ZTS
NYSE ZTS
$75.48 -1.20 (-1.56%)
At close: Aug 20, 2026 · 1:47 PM UTC

Zoetis (ZTS) FCF Margin (2012 - 2026)

Zoetis (ZTS) posted quarterly FCF Margin of 12.86% for Q1 2026, down 247.0% year-over-year from 8.75% in Q1 2025, and up 11.67% quarter-over-quarter from 11.52% in Q4 2025.

Zoetis (ZTS) FCF Margin (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported FCF Margin for 15 consecutive years, with 12.86% the latest figure, recorded in Q1 2026.

  • In Q1 2026, FCF Margin fell 247.0% year-over-year to 12.86%; the TTM figure through Mar 2026 stood at 23.53% (down 704.0% YoY), while the FY2025 annual figure was 24.12%, down 776.0% from the prior year.
  • FCF Margin climbed to 12.86% in Q1 2026 per ZTS's latest filing, from 11.52% in the prior quarter.
  • Across five years, FCF Margin topped out at 52.58% in Q3 2025 and bottomed at 9.31% in Q2 2023.
  • Historically, FCF Margin has averaged 24.21% across 5 years, with a median of 20.78% in 2024.
  • Annual changes were most pronounced in 2024 — FCF Margin soared 3638 bps — and 2025, when it plunged 2758 bps.
  • Zoetis' FCF Margin stood at 7.84% in 2022, then surged by 418 bps to 40.62% in 2023, then fell by 4 bps to 39.1% in 2024, then slumped by 71 bps to 11.52% in 2025, then climbed by 12 bps to 12.86% in 2026.
  • Business Quant data shows ZTS's FCF Margin at 12.86% in Q1 2026, 11.52% in Q4 2025, and 52.58% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn 7.41%
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 21.80%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 14.87%
5 United Therapeutics 22.19 Bn 19.53 Bn 683.80 Mn 26.25%
6 Viatris 18.68 Bn 17.79 Bn 1.46 Bn 8.76%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 13.41%
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 17.84%
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Alkermes 8.12 Bn 7.46 Bn 397.90 Mn 27.63%

Historic Data

Download Data
DateValue
Jun 30, 2026 21.80%
Mar 31, 2026 12.86%
Dec 31, 2025 11.52%
Sep 30, 2025 52.58%
Jun 30, 2025 16.63%
Mar 31, 2025 15.33%
Dec 31, 2024 39.10%
Sep 30, 2024 39.78%
Jun 30, 2024 27.06%
Mar 31, 2024 20.78%
Dec 31, 2023 40.62%
Sep 30, 2023 51.56%
Jun 30, 2023 -9.31%
Mar 31, 2023 27.30%
Dec 31, 2022 7.84%
Sep 30, 2022 26.27%
Jun 30, 2022 16.33%
Mar 31, 2022 15.36%
Dec 31, 2021 25.98%
Sep 30, 2021 26.83%